How to predict off-target adverse drug reactions (ADRs)
The Safety Margin Tool helps predict and mitigate ADRs by leveraging curated preclinical and clinical data to identify off-target effects early. Developed in partnership with Novartis, the tool:
Enables comparative safety profiling across compounds to inform lead selection and optimization
Provides mechanistic insight into adverse events, including those related to polypharmacy
Supports dosing strategy optimization to improve therapeutic safety and reduce the risk of late-stage failures